Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
BRCA1 and BRCA2 gene pathogenic variants account for most hereditary breast cancer and are increasingly used to determine eligibility for PARP inhibitor (PARPi) therapy of BRCA-related cancer. Because issues of BRCA testing in clinical practice now overlap with both preventive and therapeutic manage...
Saved in:
| Published in: | European journal of cancer (1990) Vol. 146; pp. 30 - 47 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Elsevier Ltd
01.03.2021
Elsevier Science Ltd Elsevier |
| Subjects: | |
| ISSN: | 0959-8049, 1879-0852, 1879-0852 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!